Ontology highlight
ABSTRACT:
SUBMITTER: Walker K
PROVIDER: S-EPMC9510113 | biostudies-literature | 2022 Oct
REPOSITORIES: biostudies-literature

Walker Kayleigh K Waters Lorna C LC Kelly Geoff G Muskett Frederick W FW Carr Mark D MD
Biomolecular NMR assignments 20220608 2
The co-inhibitory immune checkpoint interaction between programmed cell death-protein 1 (PD-1) and programmed cell death-ligand 1 (PD-L1) serves to regulate T-cell activation, promoting self-tolerance. Over-expression of PD-L1 is a mechanism through which tumour cells can evade detection by the immune system. Several therapeutic antibodies targeting PD-L1 or PD-1 have been approved for the treatment of a variety of cancers, however, the discovery and development of small-molecule inhibitors of P ...[more]